« Previous
Next »
The Journal of Urology
Volume 178, Issue 6
, Pages 2247-2248
, December 2007
Predicting Bacillus Calmette-Guerin Immunotherapy Effectiveness
References
- Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8
- . History of BCG and its substrains. Prog Clin Biol Res. 1989;310:35
- . Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol. 1976;116:180
- . Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value. J Urol. 1996;155:477
- . Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa (Requirement for the expression of an antitumor response). J Clin Invest. 1990;85:62
- Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer (A flow cytofluorometric analysis). Urol Res. 1991;19:45
- . Uroepithelial cells are part of a mucosal cytokine network. Infect Immun. 1994;62:2315
- . Detection of interleukin 2 in the urine of patients with superficial bladder tumors after treatment with intravesical BCG. J Urol. 1986;136:970
- . Urinary cytokines following photodynamic therapy for bladder cancer (A preliminary report). Urology. 1990;36:167
- . Activation of natural killer cells by bacillus Calmette-Guerin. Eur Urol. 2001;39:518
- . Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation. J Urol. 2004;172:1490
- Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol. 2005;6:515
- Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. J Immunol. 2003;171:6891
PII: S0022-5347(07)02262-8
doi: 10.1016/j.juro.2007.08.075
© 2007 American Urological Association. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Urology
Volume 178, Issue 6
, Pages 2247-2248
, December 2007

